KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Teva Pharmaceutical Industries (TEVA) Tax Rate (2017 - 2025)

Teva Pharmaceutical Industries' Tax Rate history spans 9 years, with the latest figure at 487.5% for Q4 2025.

  • For the quarter ending Q4 2025, Tax Rate fell 47616.0% year-over-year to 487.5%, compared with a TTM value of 14.72% through Dec 2025, up 3785.0%, and an annual FY2025 reading of 14.72%, up 3793.0% over the prior year.
  • Tax Rate for Q4 2025 was 487.5% at Teva Pharmaceutical Industries, down from 33.13% in the prior quarter.
  • The five-year high for Tax Rate was 76.4% in Q2 2022, with the low at 487.5% in Q4 2025.
  • Average Tax Rate over 5 years is 25.62%, with a median of 7.54% recorded in 2023.
  • Biggest YoY gain for Tax Rate was 21767bps in 2025; the steepest drop was -47616bps in 2025.
  • Tracing TEVA's Tax Rate over 5 years: stood at 13.71% in 2021, then crashed by -192bps to 12.57% in 2022, then surged by 164bps to 8.09% in 2023, then plummeted by -240bps to 11.34% in 2024, then plummeted by -4200bps to 487.5% in 2025.
  • Per Business Quant, the three most recent readings for TEVA's Tax Rate are 487.5% (Q4 2025), 33.13% (Q3 2025), and 38.42% (Q2 2025).